Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study

被引：5
作者：
Harrison, Tim [1 ]
Canonica, G. Walter [2 ]
Gemzoe, Kim [3 ]
Maxwell, Aoife [4 ]
Yang, Shibing [5 ]
Joksaite, Sandra [6 ]
O'Reilly, Ronan [4 ]
Van Dyke, Melissa [7 ]
Albers, Frank C. [8 ]
Kwon, Namhee [9 ]
机构：
[1] Univ Nottingham, City Hosp Nottingham, Nottingham NIHR Biomed Res Ctr, Nottingham, England
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] GSK, Global Med, Real World Study Delivery Value Evidence & Outcom, Uxbridge, Middx, England
[4] GSK, Global Med, Real World Study Delivery Value Evidence & Outcom, Uxbridge, Middx, England
[5] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[6] GSK, R&D Projects Clin Platforms & Sci, Clin Stat, Uxbridge, Middx, England
[7] GSK, Epidemiol, Upper Providence, PA USA
[8] GSK, Resp Med Franchise, Res Triangle Pk, NC USA
[9] GSK, Resp Med Franchise, GSK House, Brentford, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Severe asthma; Exacerbation;
D O I：
10.1183/13993003.congress-2019.OA2104
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA2104
引用
收藏
页数：2
相关论文
共 40 条
  • [21] Real-World Effectiveness Study of Benralizumab for Severe Eosinophilic Asthma: ZEPHYR 2
    Carstens, Donna
    Maselli, Diego J.
    Mu, Fan
    Cook, Erin E.
    Yang, Danni
    Young, Joshua A.
    Betts, Keith A.
    Genofre, Eduardo
    Chung, Yen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (07) : 2150 - +
  • [22] Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)
    Korn, Stephanie
    Milger, Katrin
    Skowasch, Dirk
    Schulz, Christian
    Mohrlang, Cordula
    Wernitz, Martin
    Paulsson, Thomas
    Hennig, Michael
    Buhl, Roland
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 541 - 552
  • [23] Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST) A real-world prospective interventional trial
    Masaki, Katsunori
    Suzukawa, Maho
    Sasano, Hitoshi
    Harada, Norihiro
    Miyazaki, Yasunari
    Katsura, Hideki
    Tagaya, Etsuko
    Terada, Junko
    Hojo, Masayuki
    Sugimoto, Naoya
    Nagase, Hiroyuki
    Kono, Yuta
    Hiranuma, Hisato
    Gon, Yasuhiro
    Takemura, Ryo
    Irie, Misato
    Nakamura, Reina
    Kabata, Hiroki
    Miyata, Jun
    Fukunaga, Koichi
    ALLERGOLOGY INTERNATIONAL, 2025, 74 (02) : 274 - 282
  • [24] Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
    Louis, Renaud
    Chanez, Pascal
    Menzella, Francesco
    Philteos, George
    Cosio, Borja G.
    Lugogo, Njira L.
    De Luiz, Gustavo
    Harrison, Tim
    Burden, Annie
    Adlington, Timothy
    Keeling, Nanna
    Kwiatek, Justin
    Gil, Esther Garcia
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [25] Late Breaking Abstract- Durable clinical benefit of benralizumab following oral corticosteroid reduction: The PONENTE study
    Menzies-Gow, Andrew
    Gurnell, Mark
    Heaney, Liam G.
    Corren, Jonathan
    Bel, Elisabeth H.
    Maspero, Jorge
    Harrison, Timothy
    Jackson, David J.
    Price, David
    Lugogo, Njira
    Kreindler, James
    Burden, Annie
    De Giorgio-Miller, Alex
    Padilla, Kelly
    Martin, Ubaldo J.
    Garcia Gil, Esther
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [26] Long-term, real-world effectiveness of biologics for severe uncontrolled asthma: The PROSPECT study
    Asai, Kazuhisa
    Iwanaga, Takashi
    Takahashi, Mai
    Eda, Masahiro
    Hirai, Takehiro
    Yabuta, Tadataka
    Makita, Naoyuki
    Tohda, Yuji
    RESPIRATORY INVESTIGATION, 2025, 63 (03) : 444 - 452
  • [27] Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization
    Dominique Hubert
    Christophe Marguet
    Jacques Benichou
    Cynthia DeSouza
    Catherine Payen-Champenois
    Nils Kinnman
    Keval Chandarana
    Anne Munck
    Isabelle Fajac
    Pulmonary Therapy, 2021, 7 : 455 - 468
  • [28] Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study
    Garcia-Moguel, Ismael
    Rosado, Ana
    Gomez-Cardenosa, Aida
    Gandolfo-Cano, Mar
    Robledo Echarren, Teresa
    Moro Moro, Maria del Mar
    Reano Martos, Ma del Mar
    Pineda-Pineda, Rafael
    Valverde-Monge, Marcela
    Martin-Arriscado Arroba, Cristina
    Dominguez-Ortega, Javier
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 623 - 632
  • [29] Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study
    Cheng, Wei
    Duan, Jiaxi
    Zhou, Aiyuan
    Zhao, Yiyang
    Yi, Rong
    Liu, Yi
    Deng, Dingding
    Li, Xin
    Zeng, Yuqin
    Peng, Yating
    Song, Qing
    Lin, Ling
    Yang, Min
    Chen, Ping
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [30] LATE-BREAKING ABSTRACT: Effect of fluticasone furoate (FF)/vilanterol (VI) on the rate of COPD exacerbations in everyday clinical practice: Results of the COPD Salford lung study (SLS)
    Vestbo, Jorgen
    Leather, David
    New, John P.
    Bakerly, Nawar Diar
    Crawford, Jodie
    Collier, Sue
    Gibson, Martin
    McCorkindale, Sheila
    Harvey, Catherine
    Yates, Louisa
    Woodcock, Ashley
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
1234